-
1
-
-
1842288943
-
Advance of studies on antitumor drugs in China
-
Wang XW, Xu B. Advance of studies on antitumor drugs in China. Bio/Pharm Quarterly (USA)1995; 1: 30-1.
-
(1995)
Bio/Pharm Quarterly (USA)
, vol.1
, pp. 30-31
-
-
Wang, X.W.1
Xu, B.2
-
2
-
-
0343029606
-
Progress of studies on cancer pharmacology in China
-
Xu B, Han L, Pan XC. Progress of studies on cancer pharmacology in China. Chin Pharmacol Bull 1996; 12: 7-10.
-
(1996)
Chin Pharmacol Bull
, vol.12
, pp. 7-10
-
-
Xu, B.1
Han, L.2
Pan, X.C.3
-
3
-
-
1842334248
-
Progress of studies on chemoimmunotherapy of primary hepatocellular carcinoma
-
Wang XW, Xu B. Progress of studies on chemoimmunotherapy of primary hepatocellular carcinoma. Cancer (China) 1996; 15: 232-3.
-
(1996)
Cancer (China)
, vol.15
, pp. 232-233
-
-
Wang, X.W.1
Xu, B.2
-
4
-
-
0004647577
-
Effect of alpha-fetoprotein on splenocyte proliferation of mice bearing ascites hepatoma-22 in vitro
-
Wang XW, Xu B. Effect of alpha-fetoprotein on splenocyte proliferation of mice bearing ascites hepatoma-22 in vitro. Shanghai J Immunol 1995; 15: 327-9.
-
(1995)
Shanghai J Immunol
, vol.15
, pp. 327-329
-
-
Wang, X.W.1
Xu, B.2
-
5
-
-
0344996593
-
Effect of alpha-fetoprotein on the growth of mouse ascites hepatoma-22 cells in vitro
-
Wang XW, Xu B. Effect of alpha-fetoprotein on the growth of mouse ascites hepatoma-22 cells in vitro. Acta Oncol Sin 1995; 5: 229-31.
-
(1995)
Acta Oncol Sin
, vol.5
, pp. 229-231
-
-
Wang, X.W.1
Xu, B.2
-
6
-
-
1842375438
-
Effect of some drugs on alpha-fetoprotein and treatment of primary hepatocellular carcinoma
-
Wang XW, Xu B. Effect of some drugs on alpha-fetoprotein and treatment of primary hepatocellular carcinoma. Bull Chin Cancer 1995; 4: 24-6.
-
(1995)
Bull Chin Cancer
, vol.4
, pp. 24-26
-
-
Wang, X.W.1
Xu, B.2
-
7
-
-
0345229871
-
Progress of studies on alpha-fetoprotein gene expression and regulation of the expression
-
Wang XW, Xu B. Progress of studies on alpha-fetoprotein gene expression and regulation of the expression. China Oncol 1996; 6: 281-4.
-
(1996)
China Oncol
, vol.6
, pp. 281-284
-
-
Wang, X.W.1
Xu, B.2
-
8
-
-
0344367083
-
L-4-Oxalysine, a new antitumor agent of natural origin
-
Wang XW, Xu B. L-4-Oxalysine, a new antitumor agent of natural origin. Med Chem Res (USA) 1996; 6: 225-32.
-
(1996)
Med Chem Res (USA)
, vol.6
, pp. 225-232
-
-
Wang, X.W.1
Xu, B.2
-
9
-
-
0344367081
-
Mechanisms of antitumor action of L-4-oxalysine, a new natural product
-
Wang XW, Xu B. Mechanisms of antitumor action of L-4-oxalysine, a new natural product. Med Chem Res (USA) 1996; 6: 233-47.
-
(1996)
Med Chem Res (USA)
, vol.6
, pp. 233-247
-
-
Wang, X.W.1
Xu, B.2
-
10
-
-
0030016980
-
L-4-Oxalysine: Its antitumor activities and mechanisms of action
-
Wang XW, Xu B. L-4-Oxalysine: its antitumor activities and mechanisms of action. Drugs Fut (Spain) 1996; 21: 727-31.
-
(1996)
Drugs Fut (Spain)
, vol.21
, pp. 727-731
-
-
Wang, X.W.1
Xu, B.2
-
11
-
-
0344133987
-
Antagonistic action of oxalysine on alpha-fetoprotein
-
Tang ZY, Ye SL, editors. Recent progress in liver cancer and hepatitis; 1996 Mar 5-7; Shanghai, China. Beijing: International Academic Publishers
-
Wang XW, Xu B. Antagonistic action of oxalysine on alpha-fetoprotein. In: Tang ZY, Ye SL, editors. Recent progress in liver cancer and hepatitis. Proceedings of 1996 Shanghai International Symposium of Liver Cancer and Hepatitis; 1996 Mar 5-7; Shanghai, China. Beijing: International Academic Publishers, 1996: 74-5.
-
(1996)
Proceedings of 1996 Shanghai International Symposium of Liver Cancer and Hepatitis
, pp. 74-75
-
-
Wang, X.W.1
Xu, B.2
-
12
-
-
0029830301
-
Anti-alpha-fetoprotein activity of L-4-oxalysine
-
Wang XW, Xu B. Anti-alpha-fetoprotein activity of L-4-oxalysine. Asia Pac J Pharmacol (Singapore) 1996; 11: 25-8.
-
(1996)
Asia Pac J Pharmacol (Singapore)
, vol.11
, pp. 25-28
-
-
Wang, X.W.1
Xu, B.2
-
13
-
-
0030767207
-
Effect of L-4-oxalysine on alpha-fetoprotein gene expression in human BEL-7404 hepatoma cells
-
in press
-
Wang XW, Xu B. Effect of L-4-oxalysine on alpha-fetoprotein gene expression in human BEL-7404 hepatoma cells. Asia Pac J Pharmacol (Singapore) 1997; 12: in press.
-
(1997)
Asia Pac J Pharmacol (Singapore)
, vol.12
-
-
Wang, X.W.1
Xu, B.2
-
14
-
-
1842291892
-
Reversal of human hepatoma cells
-
Tang ZY, Yang MH, editors. Shanghai: Shanghai Medical University Press
-
Cheng HL. Reversal of human hepatoma cells. In: Tang ZY, Yang MH, editors. Advance of primary liver cancer research. Shanghai: Shanghai Medical University Press, 1990: 328-38.
-
(1990)
Advance of Primary Liver Cancer Research
, pp. 328-338
-
-
Cheng, H.L.1
-
15
-
-
0024438311
-
Characteristics of the interaction of lycobetaine with DNA
-
Liu J, Yang SL, Xu B. Characteristics of the interaction of lycobetaine with DNA. Acta Pharmacol Sin 1989; 10: 437-42.
-
(1989)
Acta Pharmacol Sin
, vol.10
, pp. 437-442
-
-
Liu, J.1
Yang, S.L.2
Xu, B.3
-
16
-
-
0025694747
-
Some achievements of biotechnology application in anticancer drug research in China
-
Xu B, Liu J. Some achievements of biotechnology application in anticancer drug research in China. Acta Biotechnol 1990; 10: 485-90.
-
(1990)
Acta Biotechnol
, vol.10
, pp. 485-490
-
-
Xu, B.1
Liu, J.2
-
17
-
-
0008745102
-
Recent advances in pharmacologic study of natural anticancer agents in China
-
Xu B. Recent advances in pharmacologic study of natural anticancer agents in China. Mem Inst Oswaldo Cruz, Rio de Janeiro 1991; 86: 51-4.
-
(1991)
Mem Inst Oswaldo Cruz, Rio de Janeiro
, vol.86
, pp. 51-54
-
-
Xu, B.1
-
18
-
-
0344367084
-
Informational drugs and gene therapy of human diseases
-
Wang XW, Xu B. Informational drugs and gene therapy of human diseases. Chin Pharmacol Bull 1996; 12: 289-92.
-
(1996)
Chin Pharmacol Bull
, vol.12
, pp. 289-292
-
-
Wang, X.W.1
Xu, B.2
-
19
-
-
0345229866
-
Ribozymes and application in tumor therapy
-
Wang XW, Xu B. Ribozymes and application in tumor therapy. J Clin Oncol (China) 1996; 1: 65-6.
-
(1996)
J Clin Oncol (China)
, vol.1
, pp. 65-66
-
-
Wang, X.W.1
Xu, B.2
-
20
-
-
1842410499
-
Studies on screening models and methods for antitumor drugs
-
Wang XW, Xu B. Studies on screening models and methods for antitumor drugs. Chin J Pharmaceuticals 1997; 28: 39-43.
-
(1997)
Chin J Pharmaceuticals
, vol.28
, pp. 39-43
-
-
Wang, X.W.1
Xu, B.2
-
21
-
-
0021676955
-
Studies on the antifertility effect of anordrin and its analogues
-
Gu ZP, Zhu DY, Qi LM, Shen PJ. Studies on the antifertility effect of anordrin and its analogues. Acta Physiol Sin 1984; 36: 611-3.
-
(1984)
Acta Physiol Sin
, vol.36
, pp. 611-613
-
-
Gu, Z.P.1
Zhu, D.Y.2
Qi, L.M.3
Shen, P.J.4
-
22
-
-
0007525254
-
Antiturnor action of anordrin on experimental tumors
-
Xu B, Zhou PQ, Yu WJ. Antiturnor action of anordrin on experimental tumors. Tumor (China) 1989; 9: 197-9.
-
(1989)
Tumor (China)
, vol.9
, pp. 197-199
-
-
Xu, B.1
Zhou, P.Q.2
Yu, W.J.3
-
24
-
-
1842292522
-
Influence of α-anordrin on membrane fluidity and c-myc, N-ras gene expression of HL-60 cells
-
Tang WD, Xu B. Influence of α-anordrin on membrane fluidity and c-myc, N-ras gene expression of HL-60 cells. Acta Oncol Sin 1995; 5: 153-6.
-
(1995)
Acta Oncol Sin
, vol.5
, pp. 153-156
-
-
Tang, W.D.1
Xu, B.2
-
25
-
-
0021476447
-
Differentiation of human promyelocytic leukemia (HL-60) cells induced by new synthetic retinoids 4-(ethoxycarbophenyl) retinamide and 4-(hydroxycarbophenyl) retinamide
-
Song ZP, Liu YH, Han R. Differentiation of human promyelocytic leukemia (HL-60) cells induced by new synthetic retinoids 4-(ethoxycarbophenyl) retinamide and 4-(hydroxycarbophenyl) retinamide. Acta Pharm Sin 1984; 19: 576-81.
-
(1984)
Acta Pharm Sin
, vol.19
, pp. 576-581
-
-
Song, Z.P.1
Liu, Y.H.2
Han, R.3
-
26
-
-
0029796146
-
Effects of icariin on the proliferation and differentiation of HL-60 cells
-
Zhao Y, Zhang L, Cui ZY, Li SZ. Effects of icariin on the proliferation and differentiation of HL-60 cells. Chin Pharmacol Bull 1996; 12: 52-4.
-
(1996)
Chin Pharmacol Bull
, vol.12
, pp. 52-54
-
-
Zhao, Y.1
Zhang, L.2
Cui, Z.Y.3
Li, S.Z.4
-
27
-
-
1842300830
-
Antitumor drugs and apoptosis
-
Lou LG, Xu B. Antitumor drugs and apoptosis. Chin J Clin Oncol 1995; 22: 136-8.
-
(1995)
Chin J Clin Oncol
, vol.22
, pp. 136-138
-
-
Lou, L.G.1
Xu, B.2
-
28
-
-
0029899673
-
Induction of apoptosis in human leukemia K562 cells by α-anordrin
-
Lou LG, Xu B. Induction of apoptosis in human leukemia K562 cells by α-anordrin. Acta Pharmacol Sin 1996; 17: 255-8.
-
(1996)
Acta Pharmacol Sin
, vol.17
, pp. 255-258
-
-
Lou, L.G.1
Xu, B.2
-
29
-
-
0029793112
-
Apoptosis induced by α-anordrin in human premyelocytic leukemia HL-60 cells
-
Lou LG, Xu B. Apoptosis induced by α-anordrin in human premyelocytic leukemia HL-60 cells. Chin J Pharmacol Toxicol 1996; 10: 231-2.
-
(1996)
Chin J Pharmacol Toxicol
, vol.10
, pp. 231-232
-
-
Lou, L.G.1
Xu, B.2
-
30
-
-
0030971889
-
α-Anordrin-induced apoptosis of leukemia K562 cells is not prevented by cicloheximide
-
Lou LG, Xu B. α-Anordrin-induced apoptosis of leukemia K562 cells is not prevented by cicloheximide. Acta Pharmacol Sin 1997; 18: 169-72.
-
(1997)
Acta Pharmacol Sin
, vol.18
, pp. 169-172
-
-
Lou, L.G.1
Xu, B.2
-
31
-
-
0344798854
-
Drug susceptibility genes and chemotherapy of tumors
-
Wang XW, Xu B. Drug susceptibility genes and chemotherapy of tumors. Chin J Clin Oncol 1996; 23: 663-6.
-
(1996)
Chin J Clin Oncol
, vol.23
, pp. 663-666
-
-
Wang, X.W.1
Xu, B.2
-
32
-
-
1842331874
-
Action and mechanisms of suicide genes
-
Zheng BC. Action and mechanisms of suicide genes. Chem Life (China) 1996; 16: 32-3.
-
(1996)
Chem Life (China)
, vol.16
, pp. 32-33
-
-
Zheng, B.C.1
|